43 research outputs found

    Extracorporeal Membrane Oxygenation for Acute Pediatric Respiratory Failure

    Get PDF
    This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.The use of extracorporeal membrane oxygenation (ECMO) to support children with acute respiratory failure has steadily increased over the past several decades, with major advancements having been made in the care of these children. There are, however, many controversies regarding indications for initiating ECMO in this setting and the appropriate management strategies thereafter. Broad indications for ECMO include hypoxia, hypercarbia, and severe air leak syndrome, with hypoxia being the most common. There are many disease-specific considerations when evaluating children for ECMO, but there are currently very few, if any, absolute contraindications. Venovenous rather than veno-arterial ECMO cannulation is the preferred configuration for ECMO support of acute respiratory failure due to its superior side-effect profile. The approach to lung management on ECMO is variable and should be individualized to the patient, with the main goal of reducing the risk of VILI. ECMO is a relatively rare intervention, and there are likely a minimum number of cases per year at a given center to maintain competency. Patients who have prolonged ECMO runs (i.e., greater than 21 days) are less likely to survive, though no absolute duration of ECMO that would mandate withdrawal of ECMO support can be currently recommended

    Genetic analysis of grain yield, days to flowering and maturity in oilseed rape (B. napus L.) using diallel crosses.

    No full text
    Abstract Twenty one F 2 progenies derived from a 7×7 diallel crosses along with parents were evaluated for grain yield, flowering and maturity time. Due to significant genotypic effects for all traits, genetic analyses were performed on F 2 progenies including analyses of combining ability and genetic components. The Analysis of variance revealed that both additive and non-additive genetic effects were involved in controlling these traits. GCA/SCA ratios were 0.91 for days to flowering, 0.95 for days to maturity and 0.83 for grain yield which indicated that the additive gene effects were more important than non-additive gene effects for all these traits. Narrow-sense heritability was high for days to flowering (73.12%) and days to maturity (81.99%) and low for grain yield (30.15%). Heterosis in hybrids seemed to be largely determined by complementary epistasis as well as genetic distance between the parents. The spring-type varieties Tower and Regent appeared as the best parents for earliness whereas winter-type varieties D.R. and Ceres were best parents for high grain yield. It could be concluded from the study that S 1 recurrent selection would be effective to improve the performance of these genotypes for grain yield, flowering and maturity time. The selected S 1 lines from each cycle can be used in a pedigree-breeding program to identify superior genotypes

    Morbid obesity’s impact on COVID-19 patients requiring venovenous extracorporeal membrane oxygenation: The covid-19 critical care consortium database review

    No full text
    Introduction: Obesity is associated with a worse prognosis in COVID-19 patients with acute respiratory distress syndrome (ARDS). Veno-venous (V-V) Extracorporeal Membrane Oxygenation (ECMO) can be a rescue option, however, the direct impact of morbid obesity in this select group of patients remains unclear. Methods: This is an observational study of critically ill adults with COVID-19 and ARDS supported by V-V ECMO. Data are from 82 institutions participating in the COVID-19 Critical Care Consortium international registry. Patients were admitted between 12 January 2020 to 27 April 2021. They were stratified based on Body Mass Index (BMI) at 40 kg/m2. The endpoint was survival to hospital discharge. Results: Complete data available on 354 of 401 patients supported on V-V ECMO. The characteristics of the high BMI (>40 kg/m2) and lower BMI (≤40 kg/m2) groups were statistically similar. However, the ‘high BMI’ group were comparatively younger and had a lower APACHE II score. Using survival analysis, older age (Hazard Ratio, HR 1.49 per-10-years, CI 1.25–1.79) and higher BMI (HR 1.15 per-5 kg/m2 increase, CI 1.03–1.28) were associated with a decreased patient survival. A safe BMI threshold above which V-V ECMO would be prohibitive was not apparent and instead, the risk of an adverse outcome increased linearly with BMI. Conclusion: In COVID-19 patients with severe ARDS who require V-V ECMO, there is an increased risk of death associated with age and BMI. The risk is linear and there is no BMI threshold beyond which the risk for death greatly increases.</p
    corecore